Skip to main content
logo
Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.930
+0.040 (1.03%)
At close: Aug 24, 2026, 4:00 PM EDT
4.067
+0.137 (3.48%)
After-hours: Aug 24, 2026, 7:30 PM EDT

Cyclerion Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.71-3.53-3.06-5.26-44.08-51.65
Depreciation & Amortization
----0.070.47
Loss (Gain) From Sale of Assets
-----6.32
Asset Writedown & Restructuring Costs
---3.3--
Stock-Based Compensation
0.320.440.631.076.259.61
Other Operating Activities
---0.36---2.68
Change in Accounts Receivable
0.53-0.44-0.560.100.03
Change in Accounts Payable
1.140.12-0.45-1.771.140.39
Change in Other Net Operating Assets
0.270.1-0.54-2.93-40.99
Operating Cash Flow
-4.45-3.31-4.33-21.25-40.61-36.52
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.07-----0.01
Sale of Property, Plant & Equipment
-----1.46
Other Investing Activities
---10.4--
Investing Cash Flow
-0.07--10.4-1.46

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
2.93.45-1.980.0330.79
Other Financing Activities
--0.13----
Financing Cash Flow
2.93.32-5.020.0330.79

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
---0.010.0100
Net Cash Flow
-1.620.01-4.34-5.81-40.58-4.27

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-4.52-3.31-4.33-21.25-40.61-36.52
Free Cash Flow Growth
------
Free Cash Flow Margin
-237.74%-159.79%-216.65%--13673.74%-926.53%
Free Cash Flow Per Share
-1.17-1.04-1.72-9.09-18.69-18.66
Levered Free Cash Flow
-2.08-2.89-3.54-9.52-8.67-20.34
Unlevered Free Cash Flow
-2.08-2.89-3.54-9.52-8.67-20.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
1.93-0.23-1.54-4.6-2.851.41
SEC Filings: 10-K · 10-Q